AHS announces the hottest topics on tap for the 15th Triennial Heartworm Symposium scheduled for September in New Orleans.
(Image courtesy of American Heartworm Society)
The American Heartworm Society (AHS) has announced the topics to be presented at the 15th Triennial Heartworm Symposium. The symposium, titled “Heartworm Disease: The Science, the Practice, the Future,” will be held September 11-13, 2016, in New Orleans and will provide attendees with up to 20 hours of continuing education credit.
“Any veterinary practitioner who is interested in learning more about heartworm disease and its management should seriously consider attending this important symposium,” says AHS president Stephen Jones, DVM, in an AHS release. “We're going to pack in a lot of great information as well as lively panel discussions.”
Symposium attendees can expect the following topics:
Resistance/lack of efficacy. Hear findings from researchers on studies involving the genetic analysis of resistant heartworms and ways to prevent their development.
Diagnostic techniques. Learn about new research regarding heat treatment of samples, as well as information on radiographic techniques.
Recent developments in heartworm treatment protocols. Hear the latest information on heartworm treatment, including non-arsenical therapy, and recent developments in heartworm treatment protocols.
Multimodal heartworm prevention. Listen to parasitologists, entomologists and others discuss vector epidemiology and the role of vector control in heartworm prevention.
Feline heartworm disease. Feline heartworm is an underdiagnosed disease, and only a small percentage of cats are on preventives. Learn the latest regarding feline heartworm disease and heartworm associated respiratory disease (HARD).
“We strive to bring together the brightest minds in the world when it comes to understanding heartworm disease, as well as those involved in the latest research,” Jones says. “It's an information-packed meeting that is well-suited to veterinarians in practice.”
Register online here.